American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 712-720 , November 2007

The Prognostic Importance of a Small Acute Decrement in Kidney Function in Hospitalized Patients: A Systematic Review and Meta-Analysis

  • Steven G. Coca, DO

      Affiliations

    • Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven
    • Renal Section, VA Connecticut Healthcare System, West Haven
    • Department of Medicine, Yale University School of Medicine, New Haven, CT
  • ,
  • Aldo J. Peixoto, MD

      Affiliations

    • Renal Section, VA Connecticut Healthcare System, West Haven
    • Department of Medicine, Yale University School of Medicine, New Haven, CT
  • ,
  • Amit X. Garg, MD, PhD

      Affiliations

    • University of Western Ontario, London, Canada.
  • ,
  • Harlan M. Krumholz, MD

      Affiliations

    • Department of Medicine, Yale University School of Medicine, New Haven, CT
  • ,
  • Chirag R. Parikh, MD, PhD

      Affiliations

    • Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven
    • Renal Section, VA Connecticut Healthcare System, West Haven
    • Department of Medicine, Yale University School of Medicine, New Haven, CT
    • Corresponding Author InformationAddress correspondence to Chirag R. Parikh, MD, PhD, Section of Nephrology, Yale University and VAMC, Clinical Epidemiology Research Center, 950 Campbell Ave, Mail Code 151B, Bldg 35 A, Rm 219, West Haven, CT 06516.

Received 6 March 2007 ,Accepted 18 July 2007.

References 

  1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 2005;294:813–818
  2. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units—Causes, outcome, and prognostic factors of hospital mortality; A prospective, multicenter study (French Study Group on Acute Renal Failure). Crit Care Med. 1996;24:192–198
  3. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30:2051–2058
  4. Carbonell N, Blasco M, Ferreres J, et al. Sepsis and SOFA score: Related outcome for critically ill renal patients. Clin Nephrol. 2004;62:185–192
  5. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P. Prognostic factors in acute renal failure due to sepsis (Results of a prospective multicentre study. The French Study Group on Acute Renal Failure). Nephrol Dial Transplant. 1996;11:293–299
  6. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–348
  7. Holm C, Horbrand F, von Donnersmarck GH, Muhlbauer W. Acute renal failure in severely burned patients. Burns. 1999;25:171–178
  8. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail. 2003;9:13–25
  9. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–3370
  10. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8:136–141
  11. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol. 2004;15:1597–1605
  12. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: Modifying effect of preoperative renal function. Kidney Int. 2005;67:1112–1119
  13. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol. 2000;85:1110–1113
  14. Akhter MW, Aronson D, Bitar F, et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol. 2004;94:957–960
  15. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427–437
  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  18. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61–67
  19. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005;33:2194–2201
  20. Samuels JA, Finkel KW, Foringer JR, Ng C, Shaw AD: Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality. ASN Renal Week Oral Presentation Philadelphia, PA, November 2005
  21. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002;30:1495–1498
  22. Weisbord SD, Chen H, Stone RA, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol. 2006;17:2871–2877
  23. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  24. Abraham E, Naum C, Bandi V, et al. Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure. Crit Care Med. 2003;31:718–728
  25. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936
  26. Xue JL, Daniels F, Star RA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135–1142
  27. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P Workgroup ATNA. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R205–R212
  28. Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: Model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46:1038–1048
  29. Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling CR. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant. 2005;20:354–360
  30. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81:542–546
  31. Conger JD, Falk SA, Hammond WS. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int. 1991;40:21–28
  32. Miller SB, Martin DR, Kissane J, Hammerman MR. Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci U S A. 1992;89:11876–11880
  33. Sabbatini M, Pisani A, Uccello F, et al. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol. 2004;15:901–909
  34. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A. Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest. 1987;80:1232–1237
  35. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis (Auriculin Anaritide Acute Renal Failure Study Group). N Engl J Med. 1997;336:828–834
  36. Hirschberg R, Kopple J, Lipsett P, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999;55:2423–2432
  37. Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure (Anaritide Acute Renal Failure Study Group). Am J Kidney Dis. 2000;36:767–774
  38. Tumlin JA, Finkel KW, Murray PT, Samuels J, Cotsonis G, Shaw AD. Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005;46:26–34
  39. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70:199–203
  40. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238
  41. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237–244
  42. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66:1115–1122
  43. Villa P, Jimenez M, Soriano M-C, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. [see comment] Crit Care. 2005;9:R139–R143
  44. Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003;22:2113–2126
  45. Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol. 2005;58:894–901

 Originally published online as doi:10.1053/j.ajkd.2007.07.018 on October 4, 2007.

PII: S0272-6386(07)01125-0

doi: 10.1053/j.ajkd.2007.07.018

American Journal of Kidney Diseases
Volume 50, Issue 5 , Pages 712-720 , November 2007